Strongyloides stercoralis in the adult T-cell leukemia/lymphoma and the acquired immunodeficiency syndrome;STRONGYLOIDES STERCORALIS DANS LA LEUCEMIE/LYMPHOME T DE L'ADULTE ET LE SYNDROME D'IMMUNODEFICIENCE ACQUISE

Revue de Medecine Interne

Volumn 17, Issue 2, 1996, Pages 125-129

  Plumelle, Y ^a   Edouard A ^a  

^a CHU   (France)

Author keywords

AIDS; ATL; HIV; HTLV 1; Strongyloides stercoralis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RETROSPECTIVE STUDY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; T CELL LEUKEMIA; T CELL LYMPHOMA; AGED; AIDS RELATED COMPLEX; ANIMAL; HETEROZYGOTE; MARTINIQUE; MIDDLE AGED; PARASITOLOGY; PATHOPHYSIOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CARRIER STATE; FEMALE; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MARTINIQUE; MIDDLE AGED; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 0029670031     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)82961-4     Document Type: Article

References (54)

1. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine(Baltimore) 1978;57:527-44
2. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid Mortal Week Rep 1987;36(Suppl 1):3S-15S
3. Nakada K, Yamaguchi K, Furugen S et al. Monoclonal integration of HTLV 1 proviral DNA in patients with strongyloides. Int J Cancer 1987;40:145-8
4. Yamaguchi K, Matutes E, Catovsky D et al. Strongyloides stercoralis as candidate co-factor for HTLV 1 induced leukaemogenesis [Letter]. Lancet 1987;2:94-5
5. Plumelle Y, Pascaline N, N'Guyen D et al. Adult T-cell leukemia-lymphoma: a clinico-pathologic study of twenty-six patients from Martinique. Hematol Pathol 1993;7:251-62
6. Genta RM, Ottesen EA, Neva FA, Walzer PD, Tanowitz HB, Wittner M. Cellular responses in human strongyloidiasis. Am J Trop Hyg 1983;32:990-4
7. Sato Y, Shiroma Y. Peripheral lymphocyte subsets and their responsiveness in human strongyloidiasis. Clin Immunol Immunopathol 1989;53:430-8
8. Genta RM. Strongyloides stercoralis: immunobiological considerations on an unusual worm. Parasitol Today 1986;2:241-7
9. Mc Rury J, Demesias IT, Walzer PD, Huitger T, Genta RM. Specific IgE responses in human strongyloidiasis. Clin Exp Immunol 1986;65:631-8
10. Genta RM, Frei DF, Linke MJ. Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis. J Clin Microbiol 1987;25:1505-10
11. Genta RM, Lillibridge JP. Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection. J Infect Dis 1989;160:692-9
12. Genta RM, Ottesen EA, Poindexter R et al. Specific allergic sensitization to Strongyloides antigens in human strongyloidiasis. Lab Invest 1983;48:633-8
13. Genta RM, Gerhard A, Hellmam S, Hellman ME. Strongyloides stercoralis: parasitological, immunological and pathological observations in immunosuppressed dogs. Trans R Soc Trop Med Hyg 1986;80:34-41
14. Genta RM, Harper JS, Gam AA, London WI, Neva FA. Experimental disseminated strongyloidiasis in Erythrocebus patas. Am J Trop Med Hyg 1984;33:444-50
15. Grove DI, Northern C. Infection and immunity in dogs infected with a human strain of Strongyloides stercoralis. Trans R Soc Trop Med Hyg 1982;76:833-8
16. Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis. Arch Intern Med 1984;144:321-4
17. Genta RM, Douce RW, Walzer PD. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol 1986;6:1099-1103
18. Penalba C, Cerf M, Edouard A, Coulaud JP. Strongyloïdose digestive sévère. Méd Mal Infect 1982;12:412-6
19. Gill GV, Bell DR, Fifield R. Lack of immunoglobulin E response to longstanding strongyloidiasis. Clin Exp Immunol 1979;37:292-4
20. Nakada K, Kohahura M, Komada M, Hinuma Y. High incidence of HTLV 1 antibody in carriers of Strongyloides stercoralis. Lancet 1984;1:633
21. Fujita K, Tajima K, Tominaga S et al. Seroepidemiological studies of strongyloides infection in adult T-cell leukemia virus carriers in Okinawa island, Japan. Trop Med 1985;27:203-9
22. Neva FA, Murphy EL, Gam A, Hanchard B, Figueroa JP, Blattner WA. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1. N Engl J Med 1989; 320:252-3
23. Sato Y, Shiroma Y. Concurrent infections with Strongyloides stercoralis and T-cell leukemia virus and their possible effect on immune responses of host. Clin immunol Immmunopathol 1989;52:214-24
24. Dixon AC, Yanagihara ET, Kwock DW, Nakamura JM Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a non-endemic area. West J Med 1989;151:410-3
25. Newton RC, Limpuangthip P, Greenberg S, Gam ABS, Neva AF. Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am J Med 1992;92:202-8
26. Nakada K, Kohakura M, Yonahara M, Two cases of adult T-cell leukemia diagnosed during the course of strongyloidiasis. Proceedings of the 25th annual meeting of the Japan Society of Clinical Hematology, Tokyo 1983
27. O'Doherty MJ, van De Pette JE, NunanTO, Croft DN. Recurrent Strongyloides stercoralis infection in a patient with T-cell lymphoma-leukemia. Lancet 1984;i:858
28. Terada A, Utsunomiya A, Matsumoto T et al. Severe diarrhea and intestinal strongyloidiasis in a patient with adult T-cell leukemia. Acta Haematol Jpn 1985;48:1109-13
29. Pagliuca A, Layton DM, Allen S, Mufti GJ. Hyperinfection with Strongyloides after treatment for adult T-cell leukemia/lymphoma in an African immigrant. Br Med J 1988; 297:1456-7
30. Phelps KR, Ginsberg SS, Cunningham AW, Tschchler E. Dosik H. Case report: adult T-cell leukemia/lymphoma associated with recurrent strongyloides hyperinfection. Am J Med Sci 1991;302:224-8
31. Patey O, Gessain A, Breuil J et al. Seven years of recurrent severe strongyloidiasis in an HTLV-1-infected man who developped adult T-cell leukemia. AIDS 1992;6:575-9
32. Kudeken N, Kitsukawa K, Hokama A, Saito A, Kiyuna M, Toda T. A case of ATL associated with duodenal dilatation due to strongyloidiasis. Nippon Shokakibyo Gakkai Zasshi 1992;89:2623-8
33. Arakari T, Kohakura M, Amato R, Ikoshiko T, Nakamura S, Iwanaga M. Epidemiological aspects of Ss infection of Okinawa, Japan. J Trop Med Hyg 1992;95:210-3
34. Robinson RD, Lindo JF, Neva FA et al. Immunoepidemiologic studies of Ss and human T lymphotropic virus type I infection in Jamaica. J Infect Dis 1994;169:692-6
35. Satoh M, Tsukidate S, Fujita K, Yamamoto K. Strongyloides influences the elevation of adult T-cell leukemia-associated antigen antibody titer. Int Arch Allergy Appl Immunol 1991;96:95-6
36. Terry SI, Blattner W, Neva FA et al. Coincidental HTLV1 infection influences outcome of treatment of strongyloidiasis. West Indian Med J 1989;38(Suppl 1):36
37. Shikiya K, Zama O, Numura S et al. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku-Zasshi 1994;68:13-20
38. Morgello S, Soifer FM, Lin CS, Wolfe DE. Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol 1993;86:285-8
39. Celedon JC, Mathur-Wagh U, Fox J, Garcia R, Wiest PM. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature. Medicine 1994;73:256-63
40. Compels MM, Todd J, Peters BS, Main J, Pinching AJ. Disseminated strongyloidiasis in AIDS: uncommon but important. AIDS 1991;5:329-32
41. Batista N, Davila MF, Gijon H, Perez MA. Strongyloidiasis in a patient with acquired immunodeficiency syndrome. Enferm Infect Microbiol Clin 1992;10:431-2
42. Neto VA, Pasternack J, Moreira AA, Duarte MI, Campos R, Braz LM. Strongyloides stercoralis hyperinfection in the acquired immunodeficiency syndrome [Letter]. Am J Med 1989;87:602-3
43. Dias RMDS, Mangini ACS, Torres DMAGV et al. Ocorrencia de Ss em facientes portadores da sindrome de immunodeficiencis adquirida (AIDS). Rev Inst Med Trop Sao Paulo 1992;34:15-7
44. Pialoux G, Bernel P, Caudron J, Chousterman M, Meyrignac C. Syndrome d'immunodépression acquise associé à une anguillulose sévère. Presse Méd 1984:13:1960
45. Coulaud JP, Vachon F, Poznanski D. Strongyloïdose mortelle des sujets immunodéprimés. Revue de la littérature à propos d'un cas. Méd Mal Infect 1982;12:66-71
46. Maayan S, Wormser GP, Widerhorn J, Ernsto R, Kim YH, Ernst JA. Strongyloides stercoralis: hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med 1987;83:945-8
47. Petithory JC, Derouin F. AIDS and strongyloïdes in Africa. Lancet 1987;i:921
48. Vieyra-Herrera G, Becerril-Carmona G, Padua-Gabriel A, Jessurun J, Alonso de Ruiz P. Strongyloides stercoralis: hyperinfection in a patient with the acquired immune deficiency syndrome. Acta Cytol 1988;32:277-8
49. Armignacco O, Capecchi A, De Mori P, Grillo LR. Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome [Letter]. Am J Med 1989;86:258
50. Gachot B, Wolff M, Clair B, Regnier B, Vachon F. Anguillulose maligne au cours du syndrome d'immunodéficience acquis (sida). Méd Mal Infect 1989;19:786-7
51. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights, Immunol Today 1994;15:575-81
52. Nabel GJ, Rice SA, Knipe DM, Baltimore D. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 1988;239:1299-1302
53. Lusso P, De Maria A, Malnati M et al. Induction of CD4 and susceptibility to HIV-1 infection in CD8+ T lymphocytes by human herpes virus 6. Nature 1991;349:533-5
54. Sher A, Gazinelli RT, Oswald IP et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection, Immunol Rev 1992;127:183-204